Tegens 160 mg granules for oral solution venous insufficiency 20 sachets

NAME
TEGENS

PHARMACOTHERAPEUTIC CATEGORY
Capillary protective substances.

ACTIVE PRINCIPLES
Blueberry anthocyanoside complex with 36% anthocyanosides (Myrtocyan).

EXCIPIENTS
Hard capsules: mannitol, lactose, methylcellulose, citric acid, precipitated silica, magnesium stearate, gelatin (excipient of the shell). Granules for oral solution: mannitol, lactose monohydrate, methylcellulose, anhydrous citric acid, blueberry flavoring, ammonium glycyrrhizate.

INDICATIONS
Symptoms attributable to venous insufficiency; states of capillary fragility.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the listed excipients.

DOSAGE
Adults: in general, the recommended dosage schedule is the following: 80 mg capsules or sachets of granules: 2-4 per day. It is advisable to take this medicine in the morning and in the evening, with intervals of 6-8 hours. 160 mg granules capsules or sachets: 1-2 per day. It is advisable to take this medicine in the morning and in the evening, with intervals of 12-24 hours. Do not exceed the recommended dose. Pediatric population: the use of the product is reserved for adults. Method of administration: the granules, to be taken as such or dissolved in a little water, are recommended in subjects with difficulty in swallowing and in conditions of irritability of the gastric mucosa from gastric ulcerative processes.

STORAGE
Hard capsules: Store at a temperature not exceeding 30 degrees C. Granules for oral solution: no special precautions for storage.

WARNINGS
As for all symptomatic treatments it is necessary to contact your doctor if the symptoms do not improve after a short period of treatment. Clinical use has not highlighted the need for particular precautions for the use of the drug. This medicinal product contains lactose. Pediatric population: the use of the product is reserved for adults.

INTERACTIONS
No phenomena referable to interactions with other substances have ever been reported.

SIDE EFFECTS
The medicine has excellent tolerability. There have been rare reports of gastrointestinal disturbances, such as heartburn, nausea and gastric heaviness, and skin rashes. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.

PREGNANCY AND BREASTFEEDING
The safety of the drug in pregnancy has not been determined, therefore it is advisable not to administer the product during pregnancy. In breastfeeding, the product should be used in cases of real need.